<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>BedMed - Pragmatic Trials Collaborative</title>
    <meta name="description" content="A western Canadian group of primary care providers collaborating on pragmatic trials to evaluate practice changes on patient-oriented outcomes" />
    <meta name="author" content="Enhancing Alberta Primary Care Networks (EnACt)" />
    <link rel="shortcut icon" type="image/ico" href="/images/icon.ico" />
    <link href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/css/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet" media="screen">
    <!--[if lt IE 9]>
      <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/respond.js/1.4.2/respond.min.js" integrity="sha512-qWVvreMuH9i0DrugcOtifxdtZVBBL0X75r9YweXsdCHtXUidlctw7NXg5KVP3ITPtqZ2S575A0wFkvgS2anqSA==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
    <![endif]-->
    <link href='https://fonts.googleapis.com/css?family=Roboto:400,700,500,300italic,400italic,500italic,700italic,300,200' rel='stylesheet' type='text/css'>
    <link href='https://fonts.googleapis.com/css?family=Kreon:400,300,700' rel='stylesheet' type='text/css'>
    <link href='/css/pragmatic.css' rel='stylesheet' type='text/css' media="screen,print">
    <link href='/css/pragmatic-print.css' rel='stylesheet' type='text/css' media="print">
  </head>
  <body>
    <div class="container">
      <div class="row header">
        <div class="logo col-sm-4 col-md-3">
          <img src="/images/caduceus.svg" />
        </div>
        <div class="col-sm-8 col-md-9">
          <h1>Pragmatic Trials&nbsp;Collaborative</h1>
          <h2>Measuring&nbsp;What&nbsp;Matters</h2>
        </div>
      </div>
      <div class="row">
        <div class="nav col-md-3 col-sm-4">
          <nav>
            <ul>
              <li class=""><a href="/">About Us</a></li>
              <li class=""><a href="/what/">Why Pragmatic Trials?</a></li>
              <li class="section-label">Trials In Progress</li>
              <li class="section-sub"><a href="/minmed/">MinMed</a></li>
              <li class="section-sub"><a href="/optimizebp/">OptimizeBP</a></li>
              <li class="section-label">Completed Trials</li>
              <li class="section-sub"><a href="/inrange/">INRange</a></li>
              <li class="section-sub"><a href="/bedtime-diuretics/">Bedtime Diuretics</a></li>
              <li class="section-sub active"><a href="/bedmed/">BedMed</a></li>
              <li class="section-sub"><a href="/bedmed-frail/">BedMed-Frail</a></li>              
              <li class="section-label">Working to Improve Trials</li>
              <li class="section-sub"><a href="/avoiding-the-curse/">Avoiding the &quot;Winner's Curse&quot;</a></li>
              <li class=""><a href="/pdsa/">Closing the PDSA Loop</a></li>
              <li class=""><a href="/join/">How To Join</a></li>
            </ul>
          </nav>
        </div>


        <div class="col-md-9 col-sm-8 content">
          <div class="row content-title">
            <div class="col-sm-12">
              <h6>Completed Trials</h6>
              <a href="https://bedmedstudy.ca/"><img class="page-logo" src="/images/bedmed_logo.png" alt="BedMed" /></a>
              <!-- <h2>BedMed</h2> -->
              <hr />
            </div>
            <div class="col-sm-12">
              <h3>Summary</h3>
              <p class="big">BedMed was prompted by publication of the MAPEC trial<sup><a href="#ref1">1</a></sup> (N = 2,156; 255 primary outcomes) â€“ an antihypertensive medication timing trial that reported bedtime blood pressure medications to convey a 61% reduction in all-cause death or major adverse cardiovascular events compared to traditional morning use. Looking to validate these findings, BedMed worked with 436 primary care providers in 5 Canadian provinces to randomize the timing of blood pressure-lowering medications in their volunteer patients with hypertension (N = 3,357; 336 primary outcomes). We observed no difference, bedtime versus morning, in all-cause death or major cardiovascular events. Nor was there a difference in potential hypotensive, visual, or cognition-related adverse events. Another independant trial looking to validate the findings of MAPEC, the TIME trial<sup><a href="#ref2">2</a></sup> (N = 21,104; 752 primary outcomes) similarly found no difference between bedtime and morning administration.</p>
            </div>
            
            <!--
            <div class="col-sm-6 col-sm-offset-3">
              <a id="bedmed-site" href="https://bedmedstudy.ca/" target="bedmed">
                <h4>Visit the BedMed Website&emsp;<span class="glyphicon glyphicon-arrow-right" aria-hidden="true"></h4>
                <img class="media-object" id="bedmed-clock" src="/images/bedmed_clock.png" alt="BedMed website">
              </a>
            </div>
            -->  
            
            <div class="col-sm-12">
              <h3>Bottom Line</h3>
              <p>While it was safe to use blood pressure lowering medication at bedtime, no additional cardiovascular benefit was conveyed from doing so. The timing of blood pressure medication can likely be tailored to individual patient circumstances and preferences.</p>
              <h3>Trial Details &amp; Data Access</h3>
              <li><a href="https://clinicaltrials.gov/ct2/show/NCT02990663" target="bedmed-registration">Trial Registration</a></li>
              <li><a href="https://bmjopen.bmj.com/content/12/2/e059711" target="bedmed-protocol">Published Protocol</a></li>
              <li><a href="https://bmjopen.bmj.com/content/12/2/e059711" target="bedmed-results">Published Findings</a></li>
              <li><a href="https://redcap.ualberta.ca/surveys/?s=K394KPJKLWYXLF4L" target="bedmed-dataset-request">Analytic Dataset Request Form</a></li>              
              <h3>Timeline</h3>
              <p>We will continue to follow BedMed participants until late 2023, at which point we anticipate observing the same number of primary outcome events (254) as were reported in the MAPEC trial. The BedMed final analysis will be completed in spring 2024, with results to be disseminated soon thereafter.</p>
            </div>
            <div class="col-sm-12">
              <h3>Funding</h3>
              <p>The BedMed Initiative is supported in Alberta by a 3 year, $1,191,998 Partnership for Research &amp; Innovation in the Health System (PRIHS) award from <a href="http://www.aihealthsolutions.ca/">Alberta Innovates - Health Solutions</a> (AIHS).</p>
              <p>The BedMed Initiative is supported outside of Alberta by a 4 year $1,420,736 SPOR Innovative Clinical Trials Multi-Year Grant from <a href="http://www.cihr-irsc.gc.ca/e/49773.html">Canadian Institutes of Health Research</a> (CIHR).</p>
              <p>The BedMed Initiative is also supported in-kind by <a href="https://primarycareresearch.ca/">EnACt</a>.</p>
            </div>
            <div class="col-sm-12 logo-row">
              <img src="/images/ai_logo.png" alt="AI"/>
              <img src="/images/cihr_logo.png" alt="CIHR" />
              <img src="/images/enact_logo.png" alt="EnACt" />
              <img src="/images/spor_logo.png" alt="SPOR" />
            </div>
            <div class="references col-sm-12">
              <h5>References</h5>
              <ol>
                <li><a name="ref1"></a>Veerman DP, Imholz BP, Wieling W, Wesseling KH, van Montfrans GA. Circadian profile of systemic hemodynamics. <em>Hypertension</em>. Jul 1995;26(1):55-59.</li>
                <li><a name="ref2"></a>Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. <em>N Engl J Med</em>. Jun 12 2003;348(24):2407-2415.</li>
                <li><a name="ref3"></a>Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. <em>Hypertension</em>. Dec 1994;24(6):793-801.</li>
                <li><a name="ref4"></a>Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. <em>Hypertension</em>. Jun 2007;49(6):1235-1241.</li>
                <li><a name="ref5"></a>Fagard RH, Celis H, Thijs L, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. <em>Hypertension</em>. Jan 2008;51(1):55-61.</li>
                <li><a name="ref6"></a>Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. <em>Chronobiol Int</em>. Sep 2010;27(8):1629-1651.</li>
                <li><a name="ref7"></a>Carter BL, Chrischilles EA, Rosenthal G, Gryzlak BM, Eisenstein EL, Vander Weg MW. Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial. <em>J Clin Hypertens (Greenwich)</em>. Feb 2014;16(2):115-121.</li>
                <li><a name="ref8"></a>Zhao P, Xu P, Wan C, Wang Z. Evening versus morning dosing regimen drug therapy for hypertension. <em>Cochrane Database Syst Rev</em>. 2011(10):CD004184.</li>
                <li><a name="ref9"></a>Hermida RC, Crespo JJ, Dominguez-Sardina M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. <em>European heart journal</em>. 2020;41(48):4565-4576.</li>      
                <li><a name="ref10"></a>Rorie DA, Rogers A, Mackenzie IS, et al. Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study. <em>BMJ Open</em>. 2016;6(2):e010313.</li>
                </ol>
              </div>
            </div>
            <div class="clearfix"></div>
          </div>

        </div>
      </div>
    </div>
    <br /><br />
  </body>
</html>
